David J. Meyers
Johns Hopkins University(US)Johns Hopkins Medicine(US)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Histone Deacetylase Inhibitors Research, Cancer, Lipids, and Metabolism, Ubiquitin and proteasome pathways, Protein Degradation and Inhibitors
Most-Cited Works
- → The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2(2011)1,081 cited
- → Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy(2010)911 cited
- → Virtual Ligand Screening of the p300/CBP Histone Acetyltransferase: Identification of a Selective Small Molecule Inhibitor(2010)649 cited
- → A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange(2008)540 cited
- → Butyrate Greatly Enhances Derivation of Human Induced Pluripotent Stem Cells by Promoting Epigenetic Remodeling and the Expression of Pluripotency-Associated Genes(2010)416 cited
- → Inhibition of the Acetyltransferases p300 and CBP Reveals a Targetable Function for p300 in the Survival and Invasion Pathways of Prostate Cancer Cell Lines(2011)246 cited
- → Rapid and orthogonal logic gating with a gibberellin-induced dimerization system(2012)235 cited
- → Chromatin “Prepattern” and Histone Modifiers in a Fate Choice for Liver and Pancreas(2011)198 cited
- → Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domains(2010)188 cited
- → Selective Inhibition of p300 HAT Blocks Cell Cycle Progression, Induces Cellular Senescence, and Inhibits the DNA Damage Response in Melanoma Cells(2013)132 cited